Impact of hepatitis C virus infection on long-term mortality after acute myocardial infarction: a nationwide population-based, propensity-matched cohort study in Taiwan

Figures

• 

  Figure 1. The 12-year Kaplan-Meier survival curves after the first AMI among the control group and the patients with HCV and those without liver cirrhosis (panel A). Panel B shows the survival curve of the male subgroup. Panel C shows the survival curve of the female subgroup. The patients with liver cirrhosis had lower long-term survival rates than the control group and the male and female patients without cirrhosis. Additionally, the male patients with AMI with HCV but without cirrhosis had higher mortality rates than the matched controls (log-rank, P<0.0001). However, there was no difference in long-term mortality rates between female patients in the HCV group and those in the control group (log-rank, P=0.10492). Further subgroup analysis by age and PCI was also demonstrated. Panel D shows the survival curve of the younger patients (age <65 years) subgroup. Panel E shows the survival curve of the elderly patients (age ≥65 years) subgroup. Panel F shows the survival curve of the PCI subgroup. Panel G shows the survival curve of the non-PCI subgroup. The patients with liver cirrhosis had lower long-term survival rates than those in the control group or those without cirrhosis in the…

• 

  Figure 2. Forest plot evaluating the impact of HCV in different subgroups of patients after the first AMI. HCV infection influenced the long-term outcomes of subgroups of male patients, those with hypertension and those without peripheral vascular disease, previous stroke or chronic obstructive pulmonary disease. AMI, acute myocardial infarction; HCV, hepatitis C virus; PCI, percutaneous coronary intervention.